Blog Band - Page 312 of 312

1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC)Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC2. Helsinn's (fosnetupitant + palonosetron)…

Jan 2019

INSIGHTS+

PharmaShots Year in Review: Biosimilars Approvals in 2018

THE US FDA APPROVALS 1. Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for AnemiaPublished: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia2. Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives…

Jan 2019

INSIGHTS+

PharmaShots’ Most Read News of 2018

PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018 1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology PortfolioPublished: 22 Jan, 2018 | Tags:…

Insights+: The US FDA New Drug Approvals in 2018

PharmaShots Year in Review: Biosimilars Approvals in 2018

PharmaShots’ Most Read News of 2018

Contact US

OUR INFORMATION

FOLLOW US